Home » Newsletters » BioWorld Asia

BioWorld Asia

April 21, 1999

View Archived Issues

Elan Inks US$27M Antisense Drug Delivery Deal With Isis

Wellcome Trust, Pharmas Form #28M SNPs Project

Hippocampus Research Offers Alzheimers Clues, And More

European Biotech Robust And Growing, Says Report

GPC Enters Agreements With Evotec, MorphoSys

TAB In Merger Discussions After Searle Deal Crashes

Good News On Relenza Boosts Biota Stock Price

Vectura Raises #1.75M For Lipase Enzyme Work

Cytochroma Investors Give C$2.1M For Enzyme Work

Scotia Drops Cancer Drug After Interim Data Review

Genesis Research Enters Genomics Deal For Trees

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...